Literature DB >> 11026696

Primary leptomeningeal lymphoma with long-term survival: a case report.

H J Kim1, C K Ha, B S Jeon.   

Abstract

Primary leptomeningeal lymphoma (PLML) is a rare disease. The most common presentation is symptoms of increased intracranial pressure. Confusion, dysarthria, hearing loss, paraparesis and lumbosacral spinal root symptoms have also been reported. Chemotherapy and radiotherapy have been tried, but its prognosis is usually poor. We experienced a case of PLML with a relatively benign course in an 18-year-old girl. Initial diagnosis was made as idiopathic intracranial hypertension. Lumbosacral shunt was done with good response for 3 years. When headache recurred, she was reevaluated and was correctly diagnosed as PLML.

Entities:  

Mesh:

Year:  2000        PMID: 11026696     DOI: 10.1023/a:1006457415610

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  5 in total

1.  A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.

Authors:  C H Rhodes; M J Glantz; L Glantz; A Lekos; G D Sorenson; C Honsinger; N B Levy
Journal:  Cancer       Date:  1996-02-01       Impact factor: 6.860

Review 2.  Primary leptomeningeal presentation of T-cell lymphoma. Report of a patient and review of the literature.

Authors:  W L Marsh; D R Stevenson; H J Long
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

3.  Primary leptomeningeal B-cell lymphoma in a 8-year-old child.

Authors:  A Hayani; B H Venger; E Rouah; J P Laurent; D H Mahoney; K L McClain
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

4.  Primary central nervous system lymphoma without intracranial mass in a child. Diagnosis by documentation of monoclonality.

Authors:  G R Jones; W H Mason; L S Fishman; Y A DeClerck
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

Review 5.  Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature.

Authors:  D H Lachance; B P O'Neill; D R Macdonald; K A Jaeckle; T E Witzig; C Y Li; J B Posner
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

  5 in total
  3 in total

1.  Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Authors:  Jennie W Taylor; Eoin P Flanagan; Brian P O'Neill; Tali Siegal; Antonio Omuro; Lisa Deangelis; Joachim Baehring; Ryo Nishikawa; Fernando Pinto; Marc Chamberlain; Khe Hoang-Xuan; Alberto Gonzalez-Aguilar; Tracy Batchelor; Jean-Yves Blay; Agnieszka Korfel; Rebecca A Betensky; Maria-Beatriz S Lopes; David Schiff
Journal:  Neurology       Date:  2013-10-09       Impact factor: 9.910

2.  Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption.

Authors:  Marcus W C Macnealy; Herbert B Newton; John M McGregor; Susan D Bell; Abhik Ray Chaudhury; H Wayne Slone; Eric C Bourekas
Journal:  J Neurooncol       Date:  2008-08-30       Impact factor: 4.130

3.  A Case of Primary Leptomeningeal Lymphoma Presenting with Hydrocephalus Characterized by Disproportionately Large Fourth Ventricle.

Authors:  Shota Nohira; Shinji Shimato; Takashi Yamanouchi; Kazuhito Takeuchi; Taiki Yamamoto; Makoto Ito; Kyozo Kato; Toshihisa Nishizawa
Journal:  NMC Case Rep J       Date:  2021-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.